- Home
- MBI vs VOR Comparison
MBI vs VOR Comparison
Compare MBI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBI | VOR |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.2M | 562.6M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MBI | VOR |
|---|---|---|
| Price | $6.59 | $15.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $8.50 | ★ $64.78 |
| AVG Volume (30 Days) | 344.9K | ★ 664.4K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.04 | 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 90.48 | N/A |
| 52 Week Low | $3.86 | $0.13 |
| 52 Week High | $8.26 | $49.95 |
Technical Indicators
Market Signals| Indicator | MBI | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 54.23 |
| Support Level | $6.42 | $11.27 |
| Resistance Level | $6.92 | $16.95 |
| Average True Range (ATR) | 0.26 | 1.17 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 64.49 | 54.04 |
Price Performance
Historical ComparisonAbout MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.